NCT05898477
- Conditions
- Hemic and Lymphatic Diseases, Hemophagocytic Lymphohistiocytoses, Histiocytosis, +9 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
1,465 public trials
175 recruiting studies
Lymphoma trial results
NCT05366881
- Conditions
- Adnexal Diseases, Bladder Cancer, Blood Protein Disorders, +96 more
- Locations
-
- City of Hope Duarte, California, United States
- Miami Cancer Institute Miami, Florida, United States
- North Georgia Health System Gainesville, Georgia, United States
- Baptist Floyd New Albany, Indiana, United States
NCT05006482
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Lewis and Faye Manderson Cancer Center Tuscaloosa, Alabama, United States
- Kaiser Permanente-Fremont Fremont, California, United States
- Kaiser Permanente-San Francisco San Francisco, California, United States
- Helen F Graham Cancer Center Newark, Delaware, United States
NCT03829254
- Conditions
- Advanced Cancer, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- Cambridge University Hospitals NHS Foundation Trust (Addenbrookes Hospital) Cambridge, United Kingdom
- Edinburgh Cancer Centre, Western General Hospital Edinburgh, United Kingdom
- The Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
- University College London Hospital London, United Kingdom
NCT02835911
- Conditions
- Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +9 more
- Locations
-
- UNC Project Lilongwe, Malawi
Recruiting
Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma
NCT06883526
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
NCT07138547
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- People's Liberation Army General Hospital Beijing, Beijing Municipality, China
NCT07305337
- Conditions
- Adherence Interventions, Behavior, Blood Protein Disorders, +25 more
- Locations
-
- Zhongnan Hospital of Wuhan University Wuhan, Hubei, China
NCT07270263
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Embolism, +29 more
- Locations
-
- Department of Haematology & Transplantology Gdansk, Pomeranian Voivodeship, Poland
Recruiting
Mosunetuzumab for CLL MRD Clearance
NCT07052695
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
- Locations
-
- Brigham & Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States